ResMed Inc. (RMD) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Resmed Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.680 Hello and welcome to the Q4 fiscal year 2025 ResMed earnings conference call. 00:00:05.680 -- 00:00:08.720 My name is Kevin. I'll be your operator for today's call. 00:00:08.720 -- 00:00:11.700 At this time, all participants are in listen-only mode. 00:00:11.700 -- 00:00:15.100 Also, please note this conference call is being recorded. 00:00:15.100 -- 00:00:18.140 Later, we'll conduct a question and answer session. 00:00:18.140 -- 00:00:22.300 Let me hand the call over to Sally Schwartz, ResMed's Chief Investor Relations Officer. 00:00:22.300 -- 00:00:22.700 Sally, 00:00:22.480 -- 00:00:22.880 please 00:00:22.660 -- 00:00:24.800 go ahead. 00:00:24.800 -- 00:00:29.560 Thanks, Kevin. I want to welcome our listeners to ResMed's fourth quarter fiscal year 00:00:29.560 -- 00:00:34.680 2025 earnings call. We are live webcasting this call from Sydney, and the 00:00:34.680 -- 00:00:38.940 replay will be available on the investor relations section of our corporate website later 00:00:38.940 -- 00:00:44.920 today. Our earnings press release and presentation are both available online now. 00:00:44.920 -- 00:00:49.360 During today's call, we will discuss several non-GAAP measures that we believe provide 00:00:49.360 -- 00:00:54.580 useful information for investors. This information is not intended to be considered in 00:00:54.580 -- 00:00:58.900 isolation or as a substitute for GAAP financial information. 00:00:58.900 -- 00:01:02.880 We encourage you to review the supporting schedules in today's earnings press release 00:01:02.880 -- 00:01:07.720 to reconcile these non-GAAP measures with the GAAP-reported numbers. 00:01:07.720 -- 00:01:12.080 In addition, our discussion today will include forward-looking statements, including, 00:01:12.080 -- 0...